Stimulating Bladder Or Gastrointestinal Tract Patents (Class 607/40)
-
Patent number: 9643005Abstract: Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions.Type: GrantFiled: June 24, 2016Date of Patent: May 9, 2017Assignee: Incube Labs, LLCInventors: Mir Imran, Mir Hashim, Emily Arnsdorf
-
Patent number: 9616225Abstract: The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.Type: GrantFiled: March 23, 2015Date of Patent: April 11, 2017Assignee: EndoStim, Inc.Inventors: Virender K. Sharma, Edy Sofer, Paul V. Goode, Bevil Hogg, Shai Policker, Matthew Joseph Gani, Jay Miazga, Kaila Raby
-
Patent number: 9609511Abstract: A signal may be emitted by an emitter or transducer. The signal may be sensed by a sensor, such as an accelerometer. Features of a body part or portion may be one of detected, extracted, or constructed from the sensed signal. It may be determined whether the body part or portion matches that of a user, such as an authorized user, based on the features.Type: GrantFiled: July 31, 2012Date of Patent: March 28, 2017Assignee: Hewlett-Packard Development Company, L.P.Inventors: Esra Vural, Mark W Van Order, Peter S Nyholm, Stephanie Schuckers
-
Patent number: 9561367Abstract: The present specification discloses devices and methodologies for the treatment of transient lower esophageal sphincter relaxations (tLESRs). Individuals with tLESRs may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow and have improved energy storage requirements.Type: GrantFiled: September 29, 2014Date of Patent: February 7, 2017Assignee: EndoStim, Inc.Inventors: Virender K. Sharma, Matt Joseph Gani, Paul V. Goode, Bevil Hogg, Jay Miazga, Shai Policker
-
Patent number: 9517152Abstract: A responsive gastrointestinal stimulation device is provided where one or more sensors sense data corresponding to a subject or the gastrointestinal tract of a subject and responds to sensing the data by stimulating, adjusting stimulation, or stopping stimulation of the gastrointestinal tract. A stimulation device is also provided to stimulate the gastrointestinal tract to produce a sensation of satiety or to control hunger or food consumption.Type: GrantFiled: January 6, 2015Date of Patent: December 13, 2016Assignee: IntraPace, Inc.Inventor: Mir A. Imran
-
Patent number: 9498633Abstract: A method for treating incontinence includes positioning a transcutaneous electrode on skin of a patient adjacent a stimulation site; inserting a leading end of a percutaneous needle electrode through the skin adjacent the stimulation site, the percutaneous needle electrode including a lead wire disposed opposite the leading end; securing a neurostimulator unit to the transcutaneous electrode such that the neurostimulator unit is electrically coupled to the transcutaneous electrode with no lead wire disposed between the neurostimulator unit and the transcutaneous electrode, the neurostimulator unit including a pulse generator; connecting the lead wire of the percutaneous needle electrode to the neurostimulator unit for electrically coupling the needle electrode to the neurostimulator unit; and activating the pulse generator such that current pulses traverse the stimulation site by passing between the transcutaneous electrode pad and the percutaneous needle electrode.Type: GrantFiled: June 6, 2014Date of Patent: November 22, 2016Assignee: Advanced Uro-Solutions, LLCInventors: Brent D. Laing, John Green
-
Patent number: 9498624Abstract: Apparatus and methods are provided, including a bladder stimulator that includes an elongate element adapted to pass through a urethra or adapted to pass through another opening in the bladder, an expandable body coupled to said elongate element, and an array of one or more stimulator contacts coupled to the expandable body, the array including at least one contact adapted to contact a portion of a bladder of a subject when the expandable body is inserted in the bladder and expanded. A controller stimulates the portion of the bladder by driving a pulse into the bladder via the contact, the pulse having a frequency of 5 Hz-1 kHz. Other applications are also described.Type: GrantFiled: November 20, 2014Date of Patent: November 22, 2016Assignee: Nephera Ltd.Inventors: Gill Bar-Yoseph, Alon Polsky
-
Patent number: 9486625Abstract: A method and apparatus for treating a condition in a patient such as BPH, irretractable infection, cyst, fibroid, or any mass such as prostate or breast cancer, skin cancer, melanoma, or any other soft tissue cancerous or benign mass, employs a unique, three-dimensional software-controlled electronic amplifier array using arbitrary waveforms that dynamically and proportionally steer electrical currents by using two or more current vector paths, sequentially or simultaneously, through a defined area containing electrically-conductive ionic solutions so as to obtain 100% thermal heating or hyperthermia through the defined area. The condition is treated or a mass is destroyed with a minimally-invasive treatment which requires no radiation or chemotherapy which could be harmful to the patient.Type: GrantFiled: February 23, 2015Date of Patent: November 8, 2016Assignee: MedAmp Electronics, LLCInventors: E. David Crawford, William L. Nabors, Sr., Richard B. Ruse, Scott J. Bohanan
-
Patent number: 9433783Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.Type: GrantFiled: October 9, 2015Date of Patent: September 6, 2016Assignee: Medtronic, Inc.Inventors: Xuan K. Wei, Eric H. Bonde, Keith A. Miesel, Mark S. Lent, Gregory F. Molnar
-
Patent number: 9403002Abstract: Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions.Type: GrantFiled: January 16, 2015Date of Patent: August 2, 2016Assignee: Rani Therapeutics, LLCInventors: Mir A. Imran, Mir Hashim, Emily Arnsdorf
-
Patent number: 9403025Abstract: A device for conveying power from a location external to a subject to a location within the subject may include a flexible carrier and an adhesive on a first side of the carrier. A coil of electrically conductive material may be associated with the flexible carrier. A mechanical connector may be associated with the carrier opposite the adhesive, wherein the mechanical connector is configured to retain a housing and permit the housing to rotate relative to the flexible carrier. At least one electrical portion may be associated with the carrier in a manner permitting electrical connection to be maintained between the flexible carrier and the housing as the housing is rotated.Type: GrantFiled: January 20, 2015Date of Patent: August 2, 2016Inventors: Adi Mashiach, Tim Ruytjens
-
Patent number: 9393411Abstract: A method and system for bladder control are disclosed. In embodiments, a method for bladder control is provided that comprises coupling an electrode to an afferent nerve that is related to the bladder. Applying a plurality of pulse burst stimulations via the electrode causes voiding of urine from the bladder. In embodiments, the plurality of pulse burst stimulations to the afferent nerve reduces external urethral sphincter (EUS) contractions and evokes bladder contractions to expel urine from the subject. In embodiments, the plurality of pulse burst stimulations to the afferent nerve evokes bladder contractions alone to expel urine from the subject. In embodiments, a system for bladder control is provided that comprises an electrode for applying a pulse burst stimulus to an afferent nerve or dermatome to reduce reflex contractions and a signal generator for generating the pulse burst stimulus.Type: GrantFiled: June 13, 2013Date of Patent: July 19, 2016Assignee: Case Western Reserve UniversityInventors: Narendra Bhadra, Kenneth J. Gustafson, Tim Bruns, Timothy Y. Mariano
-
Patent number: 9387325Abstract: A system and method are provided for controlling stimulation of nervous tissue of a patient. The method comprises delivering a stimulation waveform to at least one electrode located proximate to nervous tissue of interest, the stimulation waveform including a series of pulses configured to excite at least one of A-beta (A?) fibers, A-delta (A?) fibers or C-fibers of the nervous tissue of interest, the stimulation waveform defined by therapy parameters. The method also provides sensing an evoked compound action potential (ECAP) signal from the nervous tissue of interest. The method also analyzes a frequency content of the ECAP signal to obtain ECAP frequency data indicative of activity by at least one type of nerve fibers from a group comprising A?, A? and C fibers. The method also determines the type of nerve fibers that were activated by the stimulation waveform based on the ECAP frequency data.Type: GrantFiled: December 19, 2014Date of Patent: July 12, 2016Assignee: PACESETTER, INC.Inventors: Xiaoyi Min, Melanie Goodman Keiser, Wenbo Hou, Bruce A. Morley
-
Patent number: 9370654Abstract: An implantable medical device and associated method deliver a therapy to an autonomic nerve. The therapy delivery includes delivering therapeutic low frequency (LF) electrical stimulation pulses to the autonomic nerve and delivering a high frequency electrical signal to the autonomic nerve during the LF frequency stimulation pulse delivery. The high frequency stimulation signal blocks activation of autonomic nerve fibers innervating a non-targeted tissue during the therapeutic LF stimulation pulse delivery.Type: GrantFiled: January 27, 2009Date of Patent: June 21, 2016Assignee: Medtronic, Inc.Inventors: Avram Scheiner, David E. Euler
-
Patent number: 9364666Abstract: Methods of using a stimulator device in the treatment of: gastrointestinal disorders such as dysphagia, gastroesophageal reflux diseases, functional dyspepsia, gastroparesis, postoperative ileus, irritable bowel syndrome, constipation, diarrhea, fecal incontinence, nausea and vomiting; gastrointestinal obstruction or pseudo-obstruction; pain and/or discomfort related to visceral organs; eating disorders, such as obesity, binge eating, bulimia, anorexia, and chemotherapy-induced emesis or emesis of other origin. The stimulator device generally includes a housing, at least two electrodes, and a pulse generator. The housing has an exterior surface and an interior surface defining a sealed interior space. The housing is constructed of bio-compatible materials and sized and shaped for transport through the gastrointestinal tract.Type: GrantFiled: May 7, 2007Date of Patent: June 14, 2016Assignee: Transtimulation Research, Inc.Inventor: Jianfeng Chen
-
Patent number: 9345879Abstract: The present specification discloses devices and methodologies for the treatment of transient lower esophageal sphincter relaxations (tLESRs). Individuals with tLESRs may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow and have improved energy storage requirements.Type: GrantFiled: March 7, 2014Date of Patent: May 24, 2016Assignee: EndoStim, Inc.Inventors: Virender K. Sharma, Matt Joseph Gani, Paul V. Goode, Bevil Hogg, Jay Miazga, Shai Policker, Kaila Raby
-
Patent number: 9333340Abstract: Various methods and apparatus for treating a condition associated with impaired glucose regulation in a subject comprising in one embodiment, applying a neural conduction block to a target nerve at a blocking site with the neural conduction block selected to at least partially block nerve pulses. In another embodiment, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to treat impaired glucose regulation. In other embodiments, up-regulation or down-regulation of various nerves, such as the vagus and its branches, and the splanchnic is used to modify the production of GLP-1 and GIP, thereby controlling glucose levels. In yet further embodiments, combinations of down-regulating and or up-regulating with or without pharmaceutical agents are used to modify the production of GLP-1 and GIP, to treat impaired glucose regulation.Type: GrantFiled: November 20, 2012Date of Patent: May 10, 2016Assignee: EnteroMedics Inc.Inventors: Arnold W. Thornton, Dennis Dong-won Kim, Mark B. Knudson, Katherine S. Tweden, Richard R. Wilson
-
Patent number: 9327109Abstract: Disclosed is an implantable, coin-sized, self-contained, leadless electroacupuncture (EA) device having at least two electrode contacts attached to the surface of its housing. The electrodes include a central cathode electrode on a bottom side of the housing, and a circumferential anode electrode that surrounds the cathode electrode. In one embodiment, the anode annular electrode is a ring electrode placed around the perimeter edge of the coin-shaped housing. The EA device is adapted to be implanted through a very small incision, e.g., less than about 2-3 cm in length, directly adjacent to a selected acupuncture site known to moderate or affect a hypertension condition of a patient. Appropriate power management circuitry within the device allows a primary battery having a relatively high internal impedance to be used without causing unacceptable dips in battery voltage when the instantaneous battery current surges.Type: GrantFiled: July 30, 2014Date of Patent: May 3, 2016Assignee: Valencia Technologies CorporationInventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara
-
Patent number: 9297845Abstract: Medical devices and methods for making and using the same are disclosed. An example medical device may include a control unit for determining an electrical leakage between a first electrode pad and a second electrode pad of an in vivo medical device. The first electrode pad may be spaced from the second electrode pad. The first electrode pad may have an active electrode and a spaced ground electrode. The second electrode pad may have an active electrode and a ground electrode. The ground electrode of the first electrode pad may be electrically connected to the ground electrode of the second electrode pad.Type: GrantFiled: March 4, 2014Date of Patent: March 29, 2016Assignee: Boston Scientific Scimed, Inc.Inventor: Prabodh Mathur
-
Patent number: 9272140Abstract: Described are implantable devices and methods for treating various disorders of the pelvic floor by means of electrical stimulation of tissue volumes at two or more locations adjacent sacral nerves or portions thereof, and/or pudendal nerves or portions thereof. Two or more electrical stimulation regimes are applied on a continuous, alternating, intermittent or other basis to the respective tissue volumes in an amount and manner effective to treat a number of disorders, including, but not limited to, urinary and/or fecal voiding dysfunctions such as constipation, incontinence disorders such as urge frequency and urinary retention disorders, sexual dysfunctions such as orgasmic and erectile dysfunction, pelvic pain, prostatitis, prostatalgia and prostatodynia.Type: GrantFiled: March 31, 2008Date of Patent: March 1, 2016Assignee: MEDTRONIC, INC.Inventor: Martin T. Gerber
-
Patent number: 9259223Abstract: A device for treating obesity of a patient, the device comprising: at least one operable stretching device implantable in the patient and adapted to stretch a portion of the patient's stomach wall, and an implantable control unit for automatically controlling the operable stretching device, when the control unit and stretching device are implanted, to stretch the stomach wall portion in connection with the patient eating such that satiety is created.Type: GrantFiled: January 27, 2014Date of Patent: February 16, 2016Inventor: Peter Forsell
-
Patent number: 9259342Abstract: Feedback systems and methods enhance obstructive and other obesity treatments by presenting feedback regarding patients' actual eating. An ingestion restricting implant body can be deployed along the gastrointestinal tract. In some embodiments, ingestion alters the implant body, which, in turn, generates signals. The generated signals can be used to inhibit unhealthy ingestion by the patient. In other embodiments, the implant body can be altered by signals so as to selectable change the restriction imposed on the gastrointestinal tract, optionally in response to ingestion events, an eating schedule, or the like. The implant body may comprise a gastric band. Sensor signals may be processed to identify ingestion and/or characterize ingestion material, and the results may be displayed on a screen for a patient or coach to view.Type: GrantFiled: December 8, 2014Date of Patent: February 16, 2016Assignee: IntraPace, Inc.Inventors: Ken Wong, John C. Potosky, Rose Province, Charles R. Brynelsen, Mir Imran
-
Patent number: 9254388Abstract: Methods, systems, and devices for endocrine and exocrine gland control, Neuro-electrical coded signals can be selected from a storage area that is representative of body organ function. The selected neuro-electrical coded signals are then transmitted to a treatment member, which is in direct contact with the body, and which then broadcasts the neuro-electrical coded signals to a specific endocrine and exocrine gland nerve or gland to modulate the gland functioning. A control module is provided for transmission to the treatment member. The control module contains the neuro-electrical coded signals which are selected and transmitted to the treatment member, and computer storage can be provided for greater storage capacity and manipulation of the neuro-electrical coded signals.Type: GrantFiled: April 22, 2014Date of Patent: February 9, 2016Assignee: Codes of Life, LLCInventor: Eleanor Schuler
-
Patent number: 9186502Abstract: A method and system for designing a therapy or for treating a condition associated with excess weight in a subject comprising applying a neural conduction block to the vagus nerve at a blocking site with the neural conduction block selected to at least partially block nerve impulses on the vagus nerve at the blocking site and administering a composition comprising an effective amount of an agent that alters the energy balance of the subject.Type: GrantFiled: February 13, 2009Date of Patent: November 17, 2015Assignee: EnteroMedics Inc.Inventors: Dennis Dong-Won Kim, Mark B. Knudson
-
Patent number: 9180293Abstract: An exemplary method for treating obesity includes an pulse generator configured to deliver electrical energy to a vagal nerve, one or more sensors configured to detect pre-prandial activity and, in response to the detection of pre-prandial activity, a pulse generator configured to deliver electrical energy to the stomach to induce satiety. Various other technologies are also disclosed.Type: GrantFiled: June 28, 2013Date of Patent: November 10, 2015Assignee: Pacesetter, Inc.Inventor: Martin Cholette
-
Patent number: 9174040Abstract: At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical stimulation includes applying a stimulation signal at the stimulation site. An optional proximal electrical blocking signal is applied to the vagus nerve at a proximal blocking site proximal to the stimulation site. The proximal blocking signal is selected to at least partially block nerve impulses at the proximal blocking site.Type: GrantFiled: September 5, 2013Date of Patent: November 3, 2015Assignee: EnteroMedics Inc.Inventors: Mark B. Knudson, Richard R. Wilson, Katherine S. Tweden, Timothy R. Conrad
-
Patent number: 9168368Abstract: A flexible catheter includes two electrical contacts in a distal region of the catheter and a distal aperture of a hose line. The electrical contacts are connected to a high frequency pulse generator for applying pulsed radio frequency energy for nerve stimulation. A temperature sensor is located in the distal region of the catheter. The flexible catheter is inserted into a region in the spinal canal and the pulsed radio frequency generator is operated, thereby applying pulsed radio frequency energy to a localized region to be treated. The temperature at the distal region of the catheter can also be monitored, and the pulsed radio frequency energy is applied in dependence on the monitored temperature. With the catheter, pain and other medical conditions being related to and influenced by a nervous system are treated.Type: GrantFiled: February 2, 2005Date of Patent: October 27, 2015Assignees: OMT GMBHInventors: Omar Omar-Pasha, Uwe Stumpp, Christian Mantsch
-
Patent number: 9168374Abstract: In general, the disclosure is directed to devices, systems, and techniques for delivering electrical stimulation to a patient with varying pulse frequencies within each burst of pulses. The pulse frequency variation within each burst of pulses may be between approximately 20 Hz and 40 Hz. In some examples, the pulse frequency may be increased, decreased, or polynomially varied within each burst. In other examples, the frequency of intrinsic nerve impulses may be detected and used to deliver pulses with the detected frequency or an inverse of the detected frequency. Electrical stimulation therapy with intra-burst pulse frequency variation may alleviate bladder dysfunction, bowel dysfunction, pain or other disorders.Type: GrantFiled: January 25, 2012Date of Patent: October 27, 2015Assignee: Medtronic, Inc.Inventor: Xin Su
-
Patent number: 9162073Abstract: A method for treating erectile dysfunction in a subject includes providing an expandable support member for engaging a wall of a blood vessel. The expandable support member includes at least one electrode connected with the expandable support member and arranged to selectively deliver electric current to modulate the autonomic nervous system (ANS). The expandable support member includes and an insulative material attached to at least a portion of the expandable support member for isolating blood flowing through the vessel from the electric current delivered by the at least one electrode. The expandable support member is implanted intravascularly so that at least a portion of the expandable support member is positioned substantially adjacent a desired location where modulation of the ANS is effective to improve erectile function. After implanting the expandable support member, electric current is delivered to the at least one electrode to effect a change in the ANS.Type: GrantFiled: May 30, 2008Date of Patent: October 20, 2015Assignee: The Cleveland Clinic FoundationInventors: Ali R. Rezai, Roy K. Greenberg, Milind Deogaonkar
-
Patent number: 9155894Abstract: Some embodiments provide a method comprising delivering neural stimulation for a neural stimulation therapy according to a programmed schedule, detecting a swallow event, and responding to the detected swallow event by overriding the programmed schedule.Type: GrantFiled: December 18, 2014Date of Patent: October 13, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: David J. Ternes, Shantha Arcot-Krishnamurthy
-
Patent number: 9149629Abstract: Systems for stimulating one or more esophageal muscle contractions are provided. The systems, which are designed to evoke esophageal motion to promote the downward movement of material, include an elongated member for placement in a patient's esophagus and at least one mechanical or electrical stimulator coupled to the elongated member. Methods for stimulating and contracting an esophageal muscle using electrodes and a generated signal sequence are also provided.Type: GrantFiled: June 26, 2012Date of Patent: October 6, 2015Assignee: E-MOTION MEDICAL LTD.Inventors: Michael Gabriel Tal, Dvir Keren, Amichay Haim Gross
-
Patent number: 9061147Abstract: The present specification discloses devices and methodologies for the treatment of transient lower esophageal sphincter relaxations (tLESRs). Individuals with tLESRs may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow and have improved energy storage requirements.Type: GrantFiled: March 7, 2014Date of Patent: June 23, 2015Assignee: EndoStim, Inc.Inventors: Virender K. Sharma, Matt Joseph Gani, Paul V. Goode, Bevil Hogg, Jay Miazga, Shai Policker, Kaila Raby
-
Publication number: 20150142074Abstract: Apparatus and methods are provided, including a bladder stimulator that includes an elongate element adapted to pass through a urethra or adapted to pass through another opening in the bladder, an expandable body coupled to said elongate element, and an array of one or more stimulator contacts coupled to the expandable body, the array including at least one contact adapted to contact a portion of a bladder of a subject when the expandable body is inserted in the bladder and expanded. A controller stimulates the portion of the bladder by driving a pulse into the bladder via the contact, the pulse having a frequency of 5 Hz-1 kHz. Other applications are also described.Type: ApplicationFiled: November 20, 2014Publication date: May 21, 2015Inventors: Gill Bar-Yoseph, Alon Polsky
-
Patent number: 9037245Abstract: A method of implanting electrically conductive leads in the gastrointestinal musculature for stimulation of target tissues involves an endoscopic approach through the esophagus. An endoscope is inserted into the esophagus of a patient. The mucosal surface of the anterior esophagus is punctured in the region encompassing the lower esophageal sphincter (LES). A tunnel is created through the submucosa and exits at the muscularis propria, adventitia, or serosal side of the stomach. The lead is navigated further to the anterior abdominal wall. A first end of the lead remains within the gastrointestinal musculature while a second end of the lead is positioned just outside the anterior abdominal wall. The first end of the lead comprises at least one electrode. An implantable pulse generator (IPG) is implanted and operably connected to the second end of the lead to provide electrical stimulation to target tissues.Type: GrantFiled: September 2, 2012Date of Patent: May 19, 2015Assignee: EndoStim, Inc.Inventors: Virender K. Sharma, Shai Policker, Paul V. Goode, Bevil Hogg
-
Patent number: 9037244Abstract: The present invention is directed to a method and apparatus for electrical stimulation of the pancreatico-biliary system. Electrode sets are placed in the pancreatico-biliary system in an arrangement that induce contractions or relaxation of the portion or whole of the pancreatico-biliary system by electrical stimulation of the surrounding tissue, muscles and nerves. The electrical stimulus is applied for periods of varying duration and varying frequency so as to produce the desired therapeutic effect, including inhibiting fat digestion or fat absorption by a patient and inducing satiety in the patient.Type: GrantFiled: February 13, 2008Date of Patent: May 19, 2015Inventor: Virender K. Sharma
-
Patent number: 9031669Abstract: Various implantable medical device embodiments stimulate an autonomic neural target from within a pulmonary artery, and comprise at least one electrode, a power supply, a neural stimulator connected to the power supply, and an anchor structure. The neural stimulator is configured to generate a neural stimulation signal for delivery to the neural stimulation target through the at least one electrode. The anchor structure is configured to chronically and securely implant the neural stimulator, the power supply and the at least one electrode within the pulmonary artery. The anchor structure, the neural stimulator, the power supply and the at least one electrode are configured to be implanted through a pulmonary valve into the pulmonary artery. In various embodiments, the neural stimulator is configured to be operational to implement a neural stimulation protocol when chronically implanted within the pulmonary artery without a wired connection through the pulmonary valve.Type: GrantFiled: August 12, 2013Date of Patent: May 12, 2015Assignee: Cardiac Pacemakers, Inc.Inventors: Yunlong Zhang, Haresh G. Sachanandani, Dan Li, Bin Mi
-
Publication number: 20150119953Abstract: A responsive gastrointestinal stimulation device is provided where one or more sensors sense data corresponding to a subject or the gastrointestinal tract of a subject and responds to sensing the data by stimulating, adjusting stimulation, or stopping stimulation of the gastrointestinal tract. A stimulation device is also provided to stimulate the gastrointestinal tract to produce a sensation of satiety or to control hunger or food consumption.Type: ApplicationFiled: January 6, 2015Publication date: April 30, 2015Inventor: Mir A. Imran
-
Publication number: 20150119952Abstract: Systems and methods for the treatment of gastroesophageal reflux disease (GERD) include at least one electrically stimulating electrode coupled to a pulse generator. Individuals with GERD are treated by implanting a stimulation device within and/or proximate the patient's lower esophageal sphincter, gastric fundus, or other nearby gastrointestinal structures and applying electrical stimulation to the patient's lower esophageal sphincter and/or fundus, in accordance with certain predefined protocols. Electrical stimulation provided by the disclosed systems results in an increase in the length of the high pressure zone of the LES and/or modulation of the receptive relaxation response of the fundus to decrease gastric pressure, creating a longer barrier to the reflux of gastric contents or increasing functional lower esophageal pressure respectively, thereby treating GERD.Type: ApplicationFiled: November 20, 2014Publication date: April 30, 2015Inventors: Virender K. Sharma, Shai Policker
-
Patent number: 9020597Abstract: The present specification discloses devices and methodologies for the treatment of GERD. Individuals with GERD may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow, have improved energy storage requirements, enable improved LES function while concurrently delivering additional health benefits, and enable improved LES function post stimulation termination.Type: GrantFiled: May 3, 2012Date of Patent: April 28, 2015Assignee: EndoStim, Inc.Inventors: Virender K. Sharma, Edy Sofer, Paul V. Goode, Bevil Hogg, Shai Policker, Matthew Joseph Gani, Jay Miazga, Kaila Raby
-
Patent number: 8992409Abstract: There is provided a method for controlling a flow of fluid and/or other bodily matter in a lumen formed by a tissue wall of a patient's organ. The method comprises gently constricting (i.e., without substantially hampering the blood circulation in the tissue wall) at least one portion of the tissue wall to influence the flow in the lumen, and stimulating the constricted wall portion to cause contraction of the wall portion to further influence the flow in the lumen. The method can be used for restricting or stopping the flow in the lumen, or for actively moving the fluid in the lumen, with a low risk of injuring the organ. Such an organ may be the esophagus, stomach, intestines, urine bladder, urethra, ureter, renal pelvis, aorta, corpus cavernosum, exit veins of erectile tissue, uterine tube, vas deferens or bile duct, or a blood vessel.Type: GrantFiled: April 12, 2010Date of Patent: March 31, 2015Inventor: Peter Forsell
-
Publication number: 20150088222Abstract: In one aspect, an ingestible, electrical device, comprises one or more electrodes comprising a biocompatible conducting material and a biocompatible insulating material; a generator connected to the one or more electrodes; and an outer casing enclosing the one or more electrodes and the generator, the outer casing configured to dissolve in an aqueous environment of the organism; wherein the one or more electrodes have a first form factor when enclosed in the outer casing and a second form factor following a dissolution of the outer casing, the first form factor is a form factor that is collapsed an increased amount relative to an amount that the second form factor is collapsed, and the second form factor is a form factor that is collapsed a decreased amount relative to an amount that the first form factor is collapsed.Type: ApplicationFiled: April 30, 2013Publication date: March 26, 2015Applicant: CARNEGIE MELLON UNIVERSITYInventor: Christopher J. Bettinger
-
Publication number: 20150087608Abstract: Methods and devices treating an autonomic nervous system associated disease condition in a subject are provided. Aspects of the invention include inducing one or more physiological response selected from the group consisting of sweating, gastric emptying, enhanced heart rate variability and enhanced quantitative sensory test responsiveness in a manner sufficient to modify the autonomic nervous system so as to treat the subject for the disease condition. The methods and devices find use in a variety of applications, e.g. in the treatment of subjects suffering from conditions arising from disorders of the autonomic nervous system.Type: ApplicationFiled: November 10, 2014Publication date: March 26, 2015Inventor: Anthony Joonkyoo Yun
-
Patent number: 8983627Abstract: A probe system for electro-stimulation and bio-feedback training of muscles in the pelvic floor region, in particular for pelvic floor physiotherapy and diagnosis, includes a probe having a probe body which is insertable into a vagina or a rectum, and a plurality of electrodes which are positioned at several locations along the length and around the circumference on the outer surface of the probe, the probe system further includes a control unit, operationally coupled to the probe, adapted for receiving EMG signals from each of the electrodes and for processing each of the signals for mapping the response of the muscles in the pelvic floor region.Type: GrantFiled: May 23, 2007Date of Patent: March 17, 2015Assignee: Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch CentrumInventors: Robertus Coenraad Maria Pelger, Theodorus Johannes Ouwerkerk, Pieternella Johanna Voorham-van der Zalm
-
Patent number: 8972014Abstract: An enuresis electroconditioner pertains to the field of medical appliances and includes a humidity sensor (2) connected to an electric circuit which is activated in the presence of a liquid. When the liquid is detected, an electric current with a frequency of 50 Hz is generated. A qualified person must calibrate the amperage of the apparatus (1), adapting it to the sensibility of each person who, when receiving the electric impulse, contracts the perineal muscles, occluding the urethra and by a reflexive action inhibiting the contraction of the bladder and preventing urine loss.Type: GrantFiled: February 14, 2011Date of Patent: March 3, 2015Inventor: Ubirajara De Oliveria Barroso JĂșnior
-
Patent number: 8972013Abstract: An implantable medical system includes an implantable medical device (IMD) and an electrode coupleable to the IMD. The electrode is operative to deliver a first electrical signal from the IMD to a neural structure. The system includes a sensor coupleable to the IMD. The sensor is operative to sense a physiological parameter. The physiological parameter may include at least one of a neurotransmitter parameter, a neurotransmitter breakdown product parameter, a neuropeptide parameter, a norepinephrine parameter, a glucocorticoid (GC) parameter, a neuromodulator parameter, a neuromodulator breakdown product parameter, an amino acid parameter, and a hormone parameter. The IMD includes a controller operative to change a parameter of the first electrical signal based upon at least one sensed physiological parameter to generate a second electrical signal and to apply the second electrical signal to the neural structure.Type: GrantFiled: March 25, 2011Date of Patent: March 3, 2015Assignee: Cyberonics, Inc.Inventor: Steven E. Maschino
-
Publication number: 20150057519Abstract: An expandable apparatus and method configured for inserting into a mammalian stomach and adapted for sensing the activity of the stomach wall. The apparatus comprising: a) an inflatable balloon insert-able into the stomach, when deflated; and b) one or more sensors, mounted to the external surface of the balloon. The inflatable balloon is adapted to attach the one or more sensors to the stomach wall, when the balloon is fully inflated in the stomach; such that the sensors are immovably affixed to the stomach wall, sufficient to sense at least one of mechanical-activity and electric-activity, emanating from the stomach wall.Type: ApplicationFiled: March 14, 2013Publication date: February 26, 2015Applicant: GEMA MEDICAL LTD.Inventors: Matan Ben-David, Moshe Rubin, Raz Bar-On, Yuval Andorn, Jacob Bortman
-
Publication number: 20150057718Abstract: The present specification discloses devices and methodologies for the treatment of transient lower esophageal sphincter relaxations (tLESRs). Individuals with tLESRs may be treated by implanting a stimulation device within the patient's lower esophageal sphincter and applying electrical stimulation to the patient's lower esophageal sphincter, in accordance with certain predefined protocols. The presently disclosed devices have a simplified design because they do not require sensing systems capable of sensing when a person is engaged in a wet swallow and have improved energy storage requirements.Type: ApplicationFiled: September 29, 2014Publication date: February 26, 2015Inventors: Virender K. Sharma, Matt Joseph Gani, Paul V. Goode, Bevil Hogg, Jay Miazga, Shai Policker
-
Patent number: 8958879Abstract: Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions.Type: GrantFiled: May 9, 2014Date of Patent: February 17, 2015Assignee: Incube Labs, LLCInventors: Mir A. Imran, Mir Hashim, Emily Arnsdorf
-
Publication number: 20150045850Abstract: An implantable system for stimulating the release of satiety hormone in a subject comprises a stimulus device (11) which is implantable in the subject and adapted to apply an electrical stimulus to a tissue of a gastrointestinal system of said subject, and a detection device which is implantable in the subject and adapted to continuously monitoring at least one of a mechanical characteristic and an electrical characteristic of the subject to detect an ingestion of food by said subject, wherein the detection device cooperates with the stimulus device (11) such that the stimulus device (11) applies said electrical stimulus in response to a detected ingestion of food.Type: ApplicationFiled: March 30, 2012Publication date: February 12, 2015Applicant: ETHICON ENDO-SURGERY, INC.Inventors: Toralf Bork, Rocco Crivelli, Mathilde Miguras, Martin Pfleiderer, Yanik Tardy, Jason L. Harris, Mark S. Ortiz, Alessandro Pastorelli, Michele D' Arcangelo
-
Patent number: 8951546Abstract: Described herein are implantable composites, kits comprising the composites, implant devices comprising the composites, and methods of making and using same, including point of use methods.Type: GrantFiled: December 21, 2009Date of Patent: February 10, 2015Assignee: SurModics Pharmaceuticals, Inc.Inventor: Thomas R. Tice